Both the expression levels of KAT2A and E2F1 were significantly up-regulated in the same 16 cancers, and E2F1 was also higher expressed in CESC, GBM, KICH, and UCEC cancers (Figure 1B,D). This evidence concerns the gene E2F1 and glioblastoma.